Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants Recommendations for a public health approach (2010 version)
- Publication Details
-
- Author(s):
-
- WHO - World Health Organisation
- Country(ies) of application:
-
- International
- Language(s):
-
- English
- Type of Publication:
- Guideline
- Primary Contact:
-
Faith McLellan
mclellanf@who.int - Publication URL:
- Open Publication URL in a new window
- Publication Scope:
-
- Management
- Prevention
- Publication Status:
- Published
- Date of publication:
- Jan 01, 2010
- Due for Review:
- -
- Diseases / Conditions Addressed
-
- MeSH Terms addressed:
-
-
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)
- Infant, Newborn, Diseases (C16.614)
-
Sexually Transmitted Diseases (C01.539.780 / C02.800)
-
Sexually Transmitted Diseases, Viral (C02.800.801)
- HIV Infections (C02.800.801.400)
-
Sexually Transmitted Diseases, Viral (C02.800.801)
-
Immune System Disorders / Immunologic Diseases (C20)
-
Immunologic Deficiency Syndromes (C20.673)
- HIV Infections (C20.673.480)
-
Immunologic Deficiency Syndromes (C20.673)
-
Pharmacologic Actions (D27.505)
- Anti-Retroviral Agents (D27.505.954.122.388.077)
-
Female Genital Diseases and Pregnancy Complications (C13)
- Pregnancy Complications (C13.703)
-
Reproduction (G08.520)
- Pregnancy (G08.520.769)
-
Virus Infections (C02)
-
RNA Virus Infections (C02.782)
- HIV Infections (C02.782.815.616.400)
-
RNA Virus Infections (C02.782)
- Pediatrics (G02.403.776.610)
-
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (C16)
- Additional Information
- Guideline key questions






